Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to GLSI-100
Related studies linked through entity extraction aliases.
Related studies linked through entity extraction aliases.